Vivanza Biosciences Q4 Results
- BSE: 530057
- NSE: -
- ISIN: INE984E01035
- Sector: Biotechnology & Drugs
BSE
2.41
0.00 (0.00%)
0.00 (0.00%)Volume1.23 K
Updated: Fri 13 Jun, 2025 | 09:21:55
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹0.48 Cr.(-89.08%)
- Operating Profit₹-0.96 Cr.(559.83%)
- Profit After Tax₹-1.00 Cr.(141.09%)
- Operating Margin-197.95%(5941.65%)
Note: Comparison is on YoY basis
Quarterly - Vivanza Biosciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 0.48 | 1.50 | -67.81% | 4.42 | -89.08% |
| Selling/ General/ Admin Expenses Total | 0.15 | 0.13 | 14.60% | 0.10 | 49.31% |
| Depreciation/ Amortization | 0.00 | 0.00 | -31.71% | 0.01 | -72.00% |
| Other Operating Expenses Total | 0.11 | 0.13 | -18.09% | 0.10 | 11.39% |
| Total Operating Expense | 1.44 | 1.38 | 4.27% | 4.57 | -68.49% |
| Operating Income | -0.96 | 0.12 | 0.00% | -0.14 | 559.83% |
| Net Income Before Taxes | -0.99 | 0.04 | 0.00% | -0.27 | 271.93% |
| Net Income | -1.00 | 0.04 | 0.00% | -0.41 | 141.09% |
| Diluted Normalized EPS | -0.25 | 0.01 | 0.00% | -0.11 | 118.24% |